User profiles for Outi Vaarala

Outi Vaarala

RIA IMED AstraZeneca
Verified email at astrazeneca.com
Cited by 23195

[HTML][HTML] AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

H Nohynek, J Jokinen, M Partinen, O Vaarala… - PloS one, 2012 - journals.plos.org
Background Narcolepsy is a chronic sleep disorder with strong genetic predisposition causing
excessive daytime sleepiness and cataplexy. A sudden increase in childhood narcolepsy …

[PDF][PDF] The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes

…, I Mattila, H Lähdesmäki, EA Franzosa, O Vaarala… - Cell host & …, 2015 - cell.com
Colonization of the fetal and infant gut microbiome results in dynamic changes in diversity,
which can impact disease susceptibility. To examine the relationship between human gut …

Environmental triggers and determinants of type 1 diabetes

M Knip, R Veijola, SM Virtanen, H Hyoty, O Vaarala… - Diabetes, 2005 - Am Diabetes Assoc
Type 1 diabetes is perceived as a chronic immune-mediated disease with a subclinical
prodromal period characterized by selective loss of insulin-producing β-cells in the pancreatic …

The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity

O Vaarala, MA Atkinson, J Neu - Diabetes, 2008 - Am Diabetes Assoc
It is often stated that type 1 diabetes results from a complex interplay between varying degrees
of genetic susceptibility and environmental factors. While agreeing with this principal, our …

Fecal microbiota composition differs between children with β-cell autoimmunity and those without

…, S Hakala, GW Welling, HJ Harmsen, O Vaarala - Diabetes, 2013 - Am Diabetes Assoc
The role of the intestinal microbiota as a regulator of autoimmune diabetes in animal models
is well-established, but data on human type 1 diabetes are tentative and based on studies …

Environmental factors in the etiology of type 1 diabetes

HK Åkerblom, O Vaarala, H Hyöty… - American journal of …, 2002 - Wiley Online Library
Outi Vaarala Outi Vaarala is professor of pediatric immunology at Linköping University,
Linköping, Sweden, and works also at the National Public Health Institute, Helsinki, Finland. Her …

[HTML][HTML] GAD treatment and insulin secretion in recent-onset type 1 diabetes

…, M Chéramy, M Pihl, O Vaarala… - … England Journal of …, 2008 - Mass Medical Soc
Background The 65-kD isoform of glutamic acid decarboxylase (GAD) is a major
autoantigen in patients with type 1 diabetes mellitus. This trial assessed the ability of alum-formulated …

Lactobacillus GG effect in increasing IFN-γ production in infants with cow's milk allergy

…, R Korpela, M Kuitunen, M Tiittanen, O Vaarala… - Journal of Allergy and …, 2004 - Elsevier
BACKGROUND: Probiotic bacteria are potentially beneficial to maturation of the infant's immune
system. OBJECTIVE: To examine the role of probiotic bacteria in treatment of cow's milk …

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

O Vaarala, K Aho, T Palosuo, G Alfthan, M Jauhiainen… - The Lancet, 1993 - Elsevier
Serum lipoproteins contain phospholipids and modified low-density lipoprotein (LDL) may
thus act as a target for antiphospholipid antibodies. Raised concentrations of IgG antibodies …

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

O Vaarala, M Mänttäri, V Manninen, L Tenkanen… - Circulation, 1995 - Am Heart Assoc
Background Data concerning the relation between anti-phospholipid (aPL) antibodies and
myocardial infarction in subjects without evidence of overt autoimmune disease are conflicting…